Saturday, March 28, 2026

 📢 First Phase of Abstract Submission Closes on March 30, 2026

Global Ophthalmology and Vision Science Congress (GOVIS 2026)

The countdown has begun! The First Phase of Abstract Submission for GOVIS 2026 is closing on March 30, 2026. This is your opportunity to present your research, share innovative ideas, and engage with global experts in ophthalmology and vision science.
                                

👁️ Why Submit Your Abstract?

Participating in GOVIS 2026 allows you to:

  • Showcase your research to an international audience
  • Gain valuable feedback from industry experts
  • Expand your academic and professional network
  • Contribute to advancements in eye care and vision science

🔬 About GOVIS 2026

The Global Ophthalmology and Vision Science Congress (GOVIS 2026) brings together researchers, clinicians, academicians, and healthcare professionals to discuss the latest innovations in ophthalmology, diagnostics, surgical techniques, and vision science.

🌍 Conference Highlights

  • CPD-accredited sessions with expert speakers
  • Oral and poster presentation opportunities
  • Networking with global professionals
  • Hybrid participation (In-person & Virtual)
  • Publication opportunities in reputed journals

📅 Event Details

📆 October 26–28, 2026
📍 Boston, Massachusetts, USA & Virtual Participation Available


🔗 Important Links

📝 Abstract Submission: https://globalophthalmologycongress.com/abstract-submission
🎟️ Registration: https://globalophthalmologycongress.com/register
🌐 Website: https://globalophthalmologycongress.com


📢 Don’t Miss Out!

Submit your abstract before the deadline and be part of one of the most impactful ophthalmology conferences of 2026.


🔖 Tags

#GOVIS2026 #AbstractSubmission #Ophthalmology #VisionScience #EyeCare #MedicalConference #ClinicalResearch #HealthcareInnovation #ResearchConference #BostonConference

No comments:

Post a Comment

Case Reports and Clinical Studies | GOVIS 2027

Real-world clinical cases often reveal the challenges that large studies may overlook. From rare ophthalmic presentations and diagnostic puz...